Rationale and design of the phase 3a development programme (ONWARDS 1–6 trials) investigating once‐weekly insulin icodec in diabetes

AIM: To describe the phase 3a ONWARDS clinical development programme investigating insulin icodec (icodec), a once‐weekly basal insulin, including the design and rationale for each of the ONWARDS 1–6 trials. MATERIALS AND METHODS: Six randomized controlled trials have been initiated in adults with t...

Descripción completa

Detalles Bibliográficos
Autores principales: Philis‐Tsimikas, Athena, Bajaj, Harpreet S., Begtrup, Kamilla, Cailleteau, Roman, Gowda, Amoolya, Lingvay, Ildiko, Mathieu, Chantal, Russell‐Jones, David, Rosenstock, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2022
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092674/
https://www.ncbi.nlm.nih.gov/pubmed/36106652
http://dx.doi.org/10.1111/dom.14871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092674/
https://www.ncbi.nlm.nih.gov/pubmed/36106652
http://dx.doi.org/10.1111/dom.14871

Ejemplares similares